2026-01-04: Auditor's report regarding status of IPO Proceeds utilization

SILVAPHL: Silva Pharmaceuticals Limited submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the month ended 30 November, 2025. To view the details, please visit: https://www.cse.com.bd/upload_media/SILVAPHL_IPO_Proceeds_Utilization_2025.pdf